Peptide
Mazdutide
Eastern dual incretin
A GLP-1/glucagon dual receptor agonist developed for metabolic disorders. Balances weight loss with potential liver health benefits.
Mechanisms
- GLP-1/Glucagon dual agonism
- Fat oxidation
- Hepatic lipid reduction
Dosing
Typical dose
3–9mg
Timing
Weekly administration. Shows promise for fatty liver in addition to weight loss.